Melatonin in mitochondrial dysfunction and related disorders

Abstract: Mitochondrial dysfunction is considered one of the major causative factors in the aging process, ischemia/reperfusion (I/R), septic shock, and neurodegenerative disorders like Parkinson’s disease (PD), Alzheimer’s disease (AD), and Huntington’s disease (HD). Increased free radical generati...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Srinivasan, Venkataramanujan, Spence, David Warren, Pandi Perumal, Seithikurippu R., Brown, Gregory M., Cardinali, Daniel Pedro
Formato:	Artículo
Lenguaje:	Inglés Inglés
Publicado:	Hindawi 2019
Materias:	MELATONINA RECEPTORES DE MELATONINA FUNCION MITOCONDRIAL ENFERMEDADES NEUROGENERATIVAS
Acceso en línea:	https://repositorio.uca.edu.ar/handle/123456789/1656
Aporte de:	Repositorio Institucional de la Universidad Católica Argentina (UCA) de Universidad Católica Argentina

Ejemplares similares

Melatonin as a therapeutic tool in ophtalmology : implication for glaucoma and uveitis
por: Rosenstein, Ruth E., et al.
Publicado: (2019)

Melatonin agonists for treatment of sleep and depressive disorders
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Potential use of melatonergic drugs in analgesia : mechanisms of action
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Malaria : therapeutic implications of melatonin
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Melatonin : clinical perspectives in neurodegeneration
por: Cardinali, Daniel Pedro
Publicado: (2019)

Melatonin agonists in primary insomnia and depression-associated insomnia : are they superior to sedative-hypnotics?
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Melatonin in chagas disease : possible therapeutic value
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Melatonin in chagas disease : possible therapeutic value
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Melatonin in septic shock : some recent concepts
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Melatonin : a pleiotropic, orchestrating regulator molecule
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Melatonin and its analogs in insomnia and depression
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: focus on Alzheimer's disease and melatonin
por: Spinedi, Eduardo J., et al.
Publicado: (2019)

Melatonin and its agonist ramelteon in Alzheimer's disease : possible therapeutic value
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Melatonin receptors (version 2019.4) in the IUPHAR/BPS Guide to pharmacology database
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022)

Chronophysiology of melatonin : therapeutical implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Some implications of melatonin use in chronopharmacology of insomnia
por: Golombek, Diego A., et al.
Publicado: (2019)

Melatonin and healthy aging
por: Cardinali, Daniel Pedro
Publicado: (2023)

Melatonin and mitochondrial dysfunction in the central nervous system
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Melatonin and brain inflammaging
por: Hardeland, Rüdiger, et al.
Publicado: (2019)

Autism spectrum disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin
por: Brown, Gregory M., et al.
Publicado: (2024)

Melatonin as an add-on treatment of COVID-19 infection : current status
por: Brown, Gregory M., et al.
Publicado: (2022)

Melatonin and human cardiovascular disease
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2019)

Jet lag, circadian rhythm sleep disturbances and depression : the role of melatonin and its analogs
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022)

Low melatonin as a contributor to SARS-CoV-2 disease
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2022)

Coadministration of melatonin and insulin improves diabetes-induced impairment of rat kidney function
por: Hajam, Younis Ahmad, et al.
Publicado: (2022)

Sleep and circadian dysregulation in depressive illness : pharmacological implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Chronobiological theories of mood disorder
por: Zaki, Nevin F. W., et al.
Publicado: (2020)

Understanding the role of sleep and its disturbances in autism spectrum disorder
por: Karthikeyan, Ramanujam, et al.
Publicado: (2022)

Melatonin, immune function and cancer
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)

Mitochondrial function, blastocyst development and live foals born after ICSI of immature 4 vitrified/warmed equine oocytes matured with or without melatonin
por: Clérico, Gabriel José, et al.
Publicado: (2020)

Melatonin and Benzodiazepine / Z Drug Abuse
por: Cardinali, Daniel Pedro, et al.
Publicado: (2020)

Chronotherapy
por: Cardinali, Daniel Pedro, et al.
Publicado: (2023)

Melatonin, mitochondria, and the metabolic syndrome
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Ma vie en noir. Fifty years with melatonin and the stone of madness
por: Cardinali, Daniel Pedro
Publicado: (2022)

Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?
por: Cardinali, Daniel Pedro
Publicado: (2019)

Cytoprotection by melatonin: The metabolic syndrome as an example
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022)

Differential expression and interaction of melatonin and thyroid hormone receptors with estrogen receptor α improve ovarian functions in letrozole-induced rat polycystic ovary syndrome
por: Ghosh, Hindole, et al.
Publicado: (2022)

Melatonin and the metabolic syndrome : physiopathologic and therapeutical implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2019)